Influence of psychosocial factors on adherence to antiretroviral treatment in HIV-positive adolescents: A review of the literature
Keywords:
Adherencia, VIH, Factores psicosociales, Apoyo social, Estigma., Adherence, HIV, Psychosocial factors, Social support, Stigma.Abstract
Introduction: the human immunodeficiency virus (HIV) remains a global health concern, and its impact on adolescents is particularly critical. Young people living with HIV face unique challenges that can significantly influence their adherence to antiretroviral therapy (ART).
Objective: to investigate the psychosocial factors that affect adherence to antiretroviral therapy among adolescents with HIV, with the aim of developing effective intervention strategies that improve treatment adherence, promote overall well-being, and reduce the impact of stigma and discrimination in this population.
Methods: the databases used for data collection were Scielo, Dialnet, and Google Scholar. The keywords included: psychosocial, adolescents with HIV, antiretroviral therapy, nursing care, prevention.
Results: the clinical manifestations of physical and emotional states are recognized by nursing staff with the objective of providing quality patient care and offering support to both the patient and their family environment. According to the literature, these findings can contribute to healthcare professionals, especially nurses, in the development of comprehensive care plans and strategies for ART adherence tailored to the needs of each adolescent and young person living with HIV.
Conclusions: current interventions that combine psychological support, health education, and the strengthening of family relationships have proven effective in improving ART adherence and the overall well-being of adolescents with HIV.
Downloads
References
1. Kim MH, Mazenga AC, Xiaoying Y, Saeed A, Paul ME, Kazembe PN, Abrams EJ. High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors. JIAS[Internet]. 2017[cited 2024 Jul 16]; 20: 21437. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.7448/IAS.20.1.21437
2. Jumare J, El-Kamary SS, Magder L, Hungerford L, Umlauf A, Franklin D, McCutchan JA. Brief Report: Body Mass Index and Cognitive Function Among HIV-1–Infected Individuals in China, India, and Nigeria. JAIDS Journal of Acquired Immune Deficiency Syndromes[Internet].2019[cited 2024 Jul 16]; 80(2): e30-e35. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6331248/pdf/nihms-1510574.pdf
3. Damulak PP, Ismail S, Abdul Manaf R, Mohd Said S, Agbaji O. Interventions to Improve Adherence to Antiretroviral Therapy (ART) in Sub-Saharan Africa: An Updated Systematic Review. International Journal of Environmental Research and Public Health[Internet]. 2021[cited 2024 Jul 16]; 18(5):2477. Available from: https://doi.org/10.3390/ijerph18052477
4. Hernández Torres JL, Benavides Torres RA, González y González V, Onofre Rodríguez DJ. Prototipo móvil para fomentar el uso de condón en jóvenes mexicanos: un estudio de caso. RCIM [Internet]. 2019 [cited 2024 Jul 15];11(2):65-79. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18592019000200065&lang=es
5. Serrano EI, Cabrera KRV, Martínez SL, Ajuria MJS, García DRG. Sistema de talleres sobre afrontamiento y autoestima para pacientes con VIH/sida del Policlínico Chiqui Gómez. Rev Sexol Soc [Internet]. 2023 [cited 2024 Jul 15];29(2): 149-169. Available from: https://revsexologiaysociedad.sld.cu/index.php/sexologiaysociedad/article/view/791/811
6. Rodríguez Gutiérrez M, Fernández Rodríguez C, Laguno M. Factores influyentes y conductas de riesgo relacionadas con el VIH en jóvenes adolescentes. Rev Multidisciplinar del Sida[Internet]. 2022[cited 2024 Jul 15]; 10(27): 6-20. Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=8585107
7. Chacón-Quesada T, Corrales-González D, Garbanzo-Núñez D, Gutiérrez-Yglesias JA, Hernández-Sandí A, Lobo-Araya A, et al. ITS Y SIDA en adolescentes: descripción, prevención y marco legal. Med. leg. Costa Rica. [Internet].Sep 2009[cited 2024 Jul 14]; 26(2) . Available from: https://www.scielo.sa.cr/scielo.php?pid=S1409-00152009000200008&script=sci_arttext&tlng=en
8. Bossonario PA, Ferreira MRL, Andrade RLP, Sousa KDL, Bonfim RO, Saita NM, et al. Factores de riesgo de infección por VIH entre adolescentes y jóvenes: revisión sistemática. Rev Lat Am Enfermagem [Internet]. 2022[cited 2024 Jul 16]; 30(spe): 3695. Available from: https://www.scielo.br/j/rlae/a/B5xmsrN5X6jvVBXWG7KsGWB/?format=pdf&lang=es
9. Estigarribia Sosa MD, Franco Pacuá F, Palacios González JM. Vista de acceso y adhesión a proceso de intervención psicosocial diferenciado para los servicios y sistemas de salud en varones gay adultos viviendo con el VIH, Paraguay, 2022. Rev Nac (Paraguay) [Internet]. 2024 [cited 2024 Jul 15]; 16(1): 081-094. Available from: https://www.revistadelnacional.com.py/index.php/inicio/article/view/148/115
10. Ballester Amal R. Aportaciones desde la psicología al tratamiento de las personas con infección por VIH/SIDA. Revista de psicopatología y psicología clínica[Internet]. 2005[cited 2024 Jul 14]; 10(1): 53-69. Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=1088471
11. Gaviria AM, Quiceno JM, Vinaccia S, Martínez LA, Otalvaro MC. Estrategias de afrontamiento y ansiedad-depresión en pacientes diagnosticados con VIH/Sida. Ter Psicol [Internet]. 2009 [cited 2024 Jul 15];27(1): 5-13. Available from: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-48082009000100001
12. Campero L, Caballero M, Kendall T, Herrera C, Zarco Á. Soporte emocional y vivencias del VIH: impactos en varones y mujeres mexicanos desde un enfoque de género. Salud Ment [Internet]. 2010 [cited 2024 Jul 15];33(5). Available from: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0185-33252010000500005
13. Macías Bestard C, Isalgué Marsillí M, Loo Muñoz NM, Acosta Sardin J. Factores de inserción laboral en adolescentes de VIH. Universidad Regional Autónoma de los Andes UNIANDES. Ambato-Ecuador; 2023[cited 2024 Jul 16]. Available from: https://www.studocu.com/ec/document/universidad-regional-autonoma-de-los-andes/salud-publica/tema-vih-ponencias-disfruta-y-aprende/100856116
14. Cabrel Castillo DL, Manco Silva K. Estrategias de afrontamiento y calidad de vida en pacientes con VIH SIDA que reciben TARGA, Hospital María Auxiliadora; 2021[cited 2024 Jul 16]. Available from: https://alicia.concytec.gob.pe/vufind/Record/UCVV_94f6a0353b365b667ad0715f2a755684/Details
15. Iglesias Serrano E, Velazco Cabrera KR, Linares Martínez S, Sáez Ajuria MJ, González García DR. Sistema de talleres sobre afrontamiento y autoestima para pacientes con VIH/sida del Policlínico Chiqui Gómez. REvSexSoc [Internet]. 31 de diciembre de 2023 [citado 2024 Jul 16];29(2). Disponible en: https://revsexologiaysociedad.sld.cu/index.php/sexologiaysociedad/article/view/791
16. Narváez Martínez L, Solano Conrado C. Apoyo social percibido y su relación con el afrontamiento en la persona adulta que vive con VIH en la región caribe colombiana. [Internet]. Barranquilla, Colombia: Corporación Universidad de la Costa; 2022 [citado: 2024 Jul 16] Disponible en: https://repositorio.cuc.edu.co/entities/publication/71f503a6-366b-45fa-894f-96cede3cde49
17. Estigarribia Sosa MD, Franco Pacuá F, Palacios González JM. Acceso y adhesión a proceso de intervención psicosocial diferenciado para los servicios y sistemas de salud en varones gay adultos viviendo con el VIH: Paraguay, 2022. Rev. Nac. (Itauguá) [Internet]. 15 de marzo de 2024 [citado 2024 Jul 16]; 16(1): 081-94. Disponible en: https://www.revistadelnacional.com.py/index.php/inicio/article/view/148
18. Eron Joseph MD, Hung Chien-Ching MD, Baril Jean-Guy MD, Slim, Jihad MD, Falcó Vicenç MD, BognerJohannes MD. Et al. Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes[Internet]. 2020[cited 2024 Jul 16]; 84(1): 60-65. Available from: https://journals.lww.com/jaids/fulltext/2020/05010/Brief_Report_Virologic_Response_by_Baseline_Viral.10.aspx
19. Zamora FJ, Dowers E, Yasin F, Ogbuagu O. Dolutegravir and lamivudine combination for the treatment of HIV-1 infection. HIV AIDS (Auckl) [Internet]. 2019[cited 2024 Jul 16];11:255-63. Available from: http://dx.doi.org/10.2147/hiv.s216067
20. Osiyemi O, De Wit S, Ajana F, Bisshop F, Portilla J, Routy JP, et al. Efficacy and safety of switching to dolutegravir/lamivudine versus continuing a tenofovir alafenamide–based 3- or 4-drug regimen for maintenance of virologic suppression in adults living with HIV-1: results through week 144 from the phase 3, noninferiority TANGO randomized trial. Clin Infect Dis [Internet]. 2022 [cited 2024 Jul 16];75(6):975-86. Available from: https://academic.oup.com/cid/article/75/6/975/6515475
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Diana Maribel Guanoluisa Aimacaña
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).
